Asthma in Children Paediatrics Causes Symptoms Diagnosis Treatment Management
Paediatrics

Asthma in Children Paediatrics Causes Symptoms Diagnosis Treatment Management

Asthma in Children (Paediatrics)

Definition

Asthma is a chronic inflammatory disease of the airways characterized by reversible airway obstruction, bronchial hyperresponsiveness, and airway inflammation, leading to recurrent episodes of wheezing, breathlessness, chest tightness, and cough, especially at night or early morning.

In children, asthma is one of the most common chronic respiratory diseases and a major cause of school absenteeism and hospital admissions.


Pathophysiology

Asthma results from chronic airway inflammation and hyperreactivity.

1. Airway Inflammation

Inflammatory cells involved:

  • Mast cells
  • Eosinophils
  • T-lymphocytes (Th2 cells)
  • Neutrophils (in severe asthma)

Inflammation causes:

  • Edema of airway mucosa
  • Mucus hypersecretion
  • Damage to airway epithelium

2. Bronchial Hyperresponsiveness

Airways become excessively sensitive to triggers such as allergens, infections, cold air, and exercise.

3. Airway Obstruction

Three main mechanisms:

  1. Bronchial smooth muscle contraction
  2. Mucosal edema
  3. Mucus plugging

4. Airway Remodeling (chronic disease)

  • Smooth muscle hypertrophy
  • Subepithelial fibrosis
  • Goblet cell hyperplasia

These changes may lead to partially irreversible obstruction if asthma is poorly controlled.


Causes and Triggers

Genetic Predisposition

  • Family history of asthma
  • Atopy
  • Allergic diseases

Environmental Triggers

  • Dust mites
  • Pollen
  • Animal dander
  • Mold

Infectious Triggers

  • Viral infections (common cause in children)
  • Respiratory viruses like Respiratory Syncytial Virus

Physical Triggers

  • Cold air
  • Exercise
  • Air pollution
  • Tobacco smoke

Other Triggers

  • Emotional stress
  • Strong odors
  • Certain drugs

Clinical Features

Symptoms

Typical symptoms include:

  • Recurrent wheezing
  • Shortness of breath
  • Chest tightness
  • Cough, especially at night or early morning

Key Pediatric Clues

  • Night-time cough
  • Exercise intolerance
  • Recurrent bronchitis
  • Wheezing with viral infections

Signs

During an asthma attack:

  • Tachypnea
  • Tachycardia
  • Expiratory wheeze
  • Prolonged expiration
  • Use of accessory muscles
  • Intercostal retractions

Severe Attack Signs

  • Silent chest
  • Cyanosis
  • Drowsiness
  • Poor respiratory effort

These indicate life-threatening asthma.


Classification of Asthma Severity

Intermittent

  • Symptoms <2 days/week
  • Night symptoms <2/month
  • Normal lung function

Mild Persistent

  • Symptoms >2 days/week
  • Night symptoms 3–4/month

Moderate Persistent

  • Daily symptoms
  • Night symptoms >1/week

Severe Persistent

  • Continuous symptoms
  • Frequent night symptoms

Investigations

1. Pulmonary Function Tests

Most useful test.

Spirometry Findings

  • Reduced FEV1
  • Reduced FEV1/FVC ratio
  • Reversibility after bronchodilator (>12%)

2. Peak Expiratory Flow Rate (PEFR)

Used for monitoring.

  • Reduced during attacks
  • Improvement after bronchodilator

3. Allergy Testing

  • Skin prick test
  • Serum IgE levels

4. Blood Tests

  • Peripheral eosinophilia
  • Elevated IgE

5. Chest X-ray

Usually normal but may show:

  • Hyperinflation
  • Flattened diaphragm

Differential Diagnosis

Conditions mimicking asthma:

  • Bronchiolitis
  • Cystic Fibrosis
  • Foreign Body Aspiration
  • Primary Ciliary Dyskinesia
  • Congenital Heart Disease

Management

Management includes:

  1. Acute attack treatment
  2. Long-term control therapy
  3. Trigger avoidance
  4. Patient education

Treatment of Acute Asthma Attack

1. Oxygen

Indication:

  • SpO₂ <94%

Dose:

  • Humidified oxygen via mask

Goal:

  • Maintain saturation >94%

2. Short Acting β2 Agonists (SABA)

Example: Salbutamol

Mechanism

Stimulates β2-adrenergic receptors → bronchodilation.

Dose

Nebulization:

  • 2.5 mg (<5 years)
  • 5 mg (>5 years)

Repeat every 20 minutes for 3 doses initially.

Pharmacokinetics

  • Onset: 5 minutes
  • Peak: 30 minutes
  • Duration: 4–6 hours

Adverse Effects

  • Tremor
  • Tachycardia
  • Hypokalemia

Contraindications

  • Severe cardiac arrhythmias

Monitoring

  • Heart rate
  • Oxygen saturation
  • Clinical improvement

3. Anticholinergic Bronchodilator

Example: Ipratropium Bromide

Mechanism

Blocks muscarinic receptors → prevents bronchoconstriction.

Dose

Nebulization:

  • 250–500 mcg every 20 minutes (first hour)

Adverse Effects

  • Dry mouth
  • Blurred vision

4. Corticosteroids

Example: Prednisolone

Mechanism

Reduces airway inflammation and edema.

Dose

  • 1–2 mg/kg/day orally
  • Max 40–60 mg

Duration

Usually 3–5 days

Adverse Effects

Short term:

  • Gastric irritation
  • Mood changes

Long term:

  • Growth suppression
  • Adrenal suppression

Monitoring

  • Growth
  • Blood pressure
  • Blood glucose

Long-Term Control Therapy

Stepwise Approach

Step 1

  • SABA as needed

Step 2

  • Low dose inhaled corticosteroid

Example: Budesonide

Dose:

  • 200–400 mcg/day

Mechanism:

  • Suppresses airway inflammation

Step 3

  • Low dose ICS + LABA

Example LABA: Salmeterol

Mechanism:

  • Long acting bronchodilation (12 hours)

Step 4

  • Medium/high dose ICS + LABA

Step 5

  • Add biologic therapy

Example: Omalizumab

Mechanism:

  • Anti-IgE monoclonal antibody

Indication:

  • Severe allergic asthma

Non-Pharmacologic Management

Trigger Avoidance

  • Avoid dust mites
  • Reduce exposure to pets
  • Avoid tobacco smoke
  • Control indoor allergens

Environmental Control

  • Use air filters
  • Wash bedding in hot water
  • Reduce humidity

Vaccination

  • Influenza vaccine
  • Pneumococcal vaccine

Asthma Education

Important components:

  • Correct inhaler technique
  • Use of spacer devices
  • Written asthma action plan
  • Recognizing early symptoms

Complications

  • Status asthmaticus
  • Respiratory failure
  • Pneumothorax
  • Growth retardation (due to steroids)

Prognosis

  • Many children outgrow asthma
  • Some develop persistent adult asthma
  • Good control with proper treatment

If you want, I can also provide the following for your Medical Knowledge Hub website:

  • SEO Title
  • SEO Description
  • SEO Keywords
  • Long-tail keywords
  • FAQ JSON
  • MCQ JSON (exam-level paediatrics questions).

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Asthma in children is a chronic inflammatory disease of the airways characterized by reversible airway obstruction, bronchial hyperresponsiveness, and recurrent episodes of wheezing, cough, shortness of breath, and chest tightness.
Common symptoms include recurrent wheezing, persistent cough especially at night or early morning, shortness of breath, chest tightness, exercise intolerance, and frequent respiratory infections.
Common triggers include viral respiratory infections, dust mites, pollen, pet dander, air pollution, tobacco smoke exposure, cold air, exercise, and strong odors.
Asthma diagnosis is based on clinical history, physical examination, spirometry showing reversible airflow obstruction, peak expiratory flow monitoring, and sometimes allergy testing.
The first-line treatment for acute asthma exacerbation is inhaled short-acting beta-2 agonists such as salbutamol delivered via nebulizer or inhaler with spacer.
Long-term control medications include inhaled corticosteroids, leukotriene receptor antagonists, long-acting beta agonists combined with inhaled corticosteroids, and biologic agents in severe asthma.
Inhaled corticosteroids reduce airway inflammation, decrease frequency of exacerbations, improve lung function, and are considered the most effective long-term controller therapy for persistent asthma.
Warning signs include severe breathlessness, inability to speak full sentences, use of accessory respiratory muscles, cyanosis, silent chest on auscultation, and oxygen saturation below 92 percent.
Some children with mild asthma may experience improvement or remission during adolescence, but others may continue to have persistent asthma into adulthood.
Prevention includes avoiding triggers, maintaining regular use of controller medications, ensuring proper inhaler technique, vaccination against respiratory infections, and following a personalized asthma action plan.